検索結果

Publications | Research & Development | SENJU Pharmaceutica

d, Double-Masked, Placebo-Controlled Phase 1/2 Study of a TRPV1 Antagonist SJP-0132 in Participants With Dry Eye Disease Tomoyuki Wada1, Kazunori Omatsu1, Stephen C. Pflugfelder2 1: Senju Pharmaceutic...

for BeelineMED” in Japan. MIEr for BeelineMED is capable of sharpening indistinct image files taken with various optical devices by installing image sharpening the algorithm developed by Logic and Des...

tion holder is Rexxam Co., Ltd. (hereinafter “Rexxam”). RET-700 is an auto ref-topographer equipped with Auto Refract Keratometer, Topographer, Wavefront, Dry eye analysis (optional) and Meibomian gla...

CRAO2) . Senju will work diligently to develop SJP-0008 as a new therapy for such a serious disease with the aim of obtaining manufacturing and marketing approval. This clinical trial is to be carried...

CRAO2) . Senju will work diligently to develop SJP-0008 as a new therapy for such a serious disease with the aim of obtaining manufacturing and marketing approval. This clinical trial is to be carried...